Ritexitinib Application Guide and Medication Instructions

Ritlecitinib (Ritlecitinib) is an oral, selective Janus kinase (JAK) inhibitor that has demonstrated unique efficacy in the treatment of autoimmune diseases. It mainly regulates the immune response and reduces the inflammatory response by inhibiting JAK kinase activity, thereby effectively alleviating the symptoms of autoimmune diseases. This article will introduce in detail the application guidelines and medication instructions of rituxitinib.

1. Indications and uses

Ritexitinib is currently mainly used to treat severe alopecia areata in adults and adolescents aged 12 years and older. Alopecia areata is a common autoimmune hair disease in which the patient's immune system abnormally attacks hair follicles, causing hair growth to slow down or stop completely, forming areas of hair loss. Ritexitinib promotes hair regeneration by inhibiting the activity of related enzymes, blocking the activation of immune cells, and reducing the attack on hair follicles.

2. Usage and dosage

The recommended dose of rituxitinib is 50 mg orally once daily. Patients can take it before or after meals, but it needs to be consistent to maintain stable drug concentrations. Capsules should be swallowed whole and do not crush, split or chew. If the patient misses a dose, he or she should take it as soon as possible. However, if the next dose is less than 8 hours away, the missed dose should be skipped and the dose should be continued at the regularly scheduled time.

3. Precautions and side effects

During the period of using ritexitinib, patients need to pay close attention to their health status and regularly monitor blood routine and liver function. Common side effects include headache, diarrhea, nausea, etc., which are generally mild and tolerable. However, ritexitinib may also cause serious side effects, such as thrombosis, serious infection, etc. Therefore, you need to strictly follow the doctor's instructions and seek medical treatment in time if you feel uncomfortable. In addition, ritexitinib may interact with certain medications, and patients should inform their doctor about all medications they are taking, including prescription drugs, over-the-counter drugs, and supplements, before use.

4. Medication for Special Populations

For special groups such as the elderly, patients with hepatic insufficiency, pregnant women and lactating women, ritexitinib should be used with caution. The elderly have a higher incidence of infection and should be treated with special caution; patients with severe liver dysfunction are generally not recommended to use it; pregnant and lactating women should consult a doctor before use to weigh the risks and benefits.

5. Storage and safekeeping

Ritexitinib should be stored at room temperature between 20°C and 25°C, with a change allowed between 15°C and 30°C, and kept in the original packaging to prevent moisture deterioration.

In short, ritexitinib is an effective drug for the treatment of alopecia areata, but it needs to be used rationally under the guidance of a doctor, and attention should be paid to monitoring side effects to ensure the safety and effectiveness of the drug.

References:

https://www.drugs.com/history/litfulo.html

https://www.drugs.com/pro/litfulo.html#s-44425-7